//
P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Dual antiplatelet therapy: how, how long, and in which patients?
Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy
Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)